The role of eosinophils in chronic spontaneous urticaria

التفاصيل البيبلوغرافية
العنوان: The role of eosinophils in chronic spontaneous urticaria
المؤلفون: Sabine Altrichter, Marcus Maurer, Pavel Kolkhir, Qingqing Jiao, Martin Metz, Per Stahl Skov, Martin K. Church, Stefan Frischbutter, Jie Shen Fok
المصدر: Altrichter, S, Frischbutter, S, Fok, J S, Kolkhir, P, Jiao, Q, Skov, P S, Metz, M, Church, M K & Maurer, M 2020, ' The role of eosinophils in chronic spontaneous urticaria ', Journal of Allergy and Clinical Immunology, vol. 145, no. 6, pp. 1510-1516 . https://doi.org/10.1016/j.jaci.2020.03.005Test
بيانات النشر: Elsevier BV, 2020.
سنة النشر: 2020
مصطلحات موضوعية: 0301 basic medicine, Immunology, 03 medical and health sciences, 0302 clinical medicine, Reslizumab, Urticaria chronic spontaneous urticaria, medicine, Humans, Immunology and Allergy, eosinophil, Chronic Urticaria, Mast Cells, CCL11, Skin, Eosinophil cationic protein, biology, business.industry, Antibodies, Monoclonal, Eosinophil, Mast cell, Eosinophils, 030104 developmental biology, medicine.anatomical_structure, 030228 respiratory system, Chronic Disease, Major basic protein, biology.protein, Cytokines, mast cell, CCL24, business, Eosinophil peroxidase, medicine.drug
الوصف: Chronic spontaneous urticaria (CSU) is considered to be primarily a mast cell–driven disease. However, recent evidence suggests that eosinophils may also have an axial role in symptomology. Histologic studies have demonstrated the presence of both eosinophils and eosinophil granules, indicative of activation, in CSU lesions. Although many allergic and inflammatory conditions are associated with a peripheral blood eosinophilia, the converse appears to be the case in CSU, with a peripheral blood eosinopenia being observed in many patients. Possible mechanisms include the depletion of blood eosinophils by recruitment into the skin during active disease and immunologic destruction in the blood. We also address in some detail the interactions between eosinophils and mast cells, particularly the cytokine cross-talk of these cells and mediator release possibly leading to clinical symptoms. Also, activation by eosinophil proteins of the coagulation pathway leads to the generation of thrombin and increased mast cell degranulation. Finally, treatments aimed at reducing eosinophil accumulation and activation, such as the anti–IL-5 antibodies mepolizumab, reslizumab, and benralizumab, have been reported to reduce CSU symptoms. Clearly, a new picture of an important role of eosinophils in the pathogenesis of CSU is emerging.
تدمد: 0091-6749
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::defa9830420cd5b9a76a7eba20004e2cTest
https://doi.org/10.1016/j.jaci.2020.03.005Test
حقوق: CLOSED
رقم الانضمام: edsair.doi.dedup.....defa9830420cd5b9a76a7eba20004e2c
قاعدة البيانات: OpenAIRE